Antiretroviral therapy in children: Indian experience

Indian Pediatrics

Volumn 44, Issue 5, 2007, Pages 339-343

  Natu, Sanjay A ^a,b   Daga, S R ^a  

^a B J MEDICAL COLLEGE   (India)

^b NONE   (India)

Author keywords

Absolute lymphocyte count; Adherence; Fixed drug combination; Nevirapine; Pediatric HAART

Indexed keywords

ANTIRETROVIRUS AGENT; LAMIVUDINE PLUS NEVIRAPINE PLUS STAVUDINE;

ARTICLE; BODY WEIGHT; CD4 LYMPHOCYTE COUNT; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEASIBILITY STUDY; FEMALE; FOLLOW UP; GASTRITIS; HEPATITIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; INTERVENTION STUDY; LYMPHOCYTE COUNT; MALE; PATIENT COMPLIANCE; STATISTICAL SIGNIFICANCE; TERTIARY HEALTH CARE; TRAVEL; TREATMENT OUTCOME; WORLD HEALTH ORGANIZATION;

ANTI-RETROVIRAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CHILD; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; FEASIBILITY STUDIES; FEMALE; GUIDELINE ADHERENCE; HIV INFECTIONS; HUMANS; INDIA; INFANT; LAMIVUDINE; MALE; NEVIRAPINE; PATIENT COMPLIANCE; PILOT PROJECTS; STAVUDINE;

EID: 34249072203     PISSN: 00196061     EISSN: 00196061     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Manual for management of HIV/AIDS in children. WHO, UNICEF, IAP, NACO. 2004-2005. Available from: URL: http://www.whoindia.org/EN/Section3/Section123/ Section375/Section377_983.htm. Accessed March 10, 2006.
2. Working Group on Antiretroviral Therapy and Medical Management of HIV-Infected Children. Guidelines for the Use of Anti-retroviral Agents in Pediatric HIV Infection. March 24, 2005; Available from: URL: http://AIDSinfo.nih.gov. Accessed January 20, 2006.
3. Laurent C, Kouanfack C, Koukka-Shiro S, Nkoue N, Bourgeois A, Calmy A. Effectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine, and lamivudine in HIV-1-infected adults in Cameroon: Open-label multicentre trial. Lancet 2004; 364: 29-34.
4. Osborne CM. The challenge of diagnosing childhood tuberculosis in a developing country. Arch Dis Child 1995; 72: 369-374.
5. Statement. Management of Pediatric Tuberculosis under the Revised National Tuberculosis Control Program (RNTCP). Indian Pediatr 2004; 41: 901-905.
6. Scaling up antiretroviral therapy in resource-limited settings: Treatment guidelines for a public health approach WHO 2003 revision. Available from: URL: www.who.int/3by5/publications/guidelines/en/arv_guidelines.pdf. Accessed on April 1, 2006.
7. Verweel G, van Rossum AM, Hartwig NG, Wolfs TF, Scherpbier HJ, de Groot R. Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth. Pediatrics. 2002;109:E25
8. Nachman SA, Lindsey JC, Moye J, Stanley KE, Johnson GM, Krogstad PA, et al. Pediatric AIDS Clinical Trials Group 377 Study Team. Growth of human immunodeficiency virus-infected children receiving highly activeantiretroviral therapy. Pediatr Infect Dis J 2005; 24:352-357.
9. Lodha R, Upadhyay A, Kabra SK. Antiretroviral Therapy in HIV-1 Infected Children. Indian Pediatr 2005; 42: 789-796.
10. Puthanakit T, Oberdorfer A, Akarathum N, Kanjanavanit S, Wannarit P, Sirisanthana T, et al. Efficacy of highly active antiretroviral therapy in HIV-infected children participating in Thailand's National Access to Antiretroviral Program. Clin Infect Dis. 2005; 41: 100-107.
11. Shapiro NI, Karras DJ, Leech SH, Heilpern KL. Absolute lymphocyte count as a predictor of CD4 count. Ann Emerg Med 1998; 32: 323-328.
12. Beck EJ, Kupek EJ, Gompels MM, Pinching AJ. Correlation between total and CD4 lymphocyte counts in HIV infection: not making the good an enemy of the not so perfect. Int J STD AIDS. 1996; 7: 422-428.
13. Bertolli J, Hsu HW, Sukalac T, Williamson J, Peters V, Frederick T, et al. Hospitalization trends among children and youths with perinatal human immunodeficiency virus infection, 1990-2002. Pediatr Infect Dis J 2006; 25: 628-633.
14. Sanchez JM, Ramos Amador JT, Fernandez de Miguel S, Gonzalez Tomee MI, Rojo Conejo P, Ferrnado Vivas P, et al. Impact of highly active antiretroviral therapy on the morbidity and mortality in Spanish human immunodeficiency virus-infected children. Pediatr Infect Dis J 2003;22:863-867.
15. Resino S, Resino R, Maria Bellon J, Micheloud D, Gutierrez MD, de Jose MI, et al. Clinical outcome improves with highly active antiretroviral therapy in vertically HIV type-1 infected children. Clin Infect Dis 2006;43:243-252 .